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The female advantage
Female sex is associated with a survival advantage in a vari-
ety of cancer types, although this advantage is considerably 
higher in melanoma than in any other form of cancer. On 
the heels of a previous study that demonstrated an advantage 
for females in stage I or II (localized) melanoma, Joosse and 
colleagues conducted a study to investigate the prognos-
tic role of sex in metastatic melanoma. This study enrolled 
2,732 stage III and 1,306 stage IV patients, with an equal 
distribution of males and females. Even after adjustment for 
all available confounders, a survival advantage for females 
remained statistically significant in both stage III and stage 
IV disease. Combining these results with previous study find-
ings indicated that the female advantage gradually declines 
as the disease advances. The female advantage, however, was 
consistent across all end points, was independent of other 
prognostic factors, and persisted through all stages of mela-
noma progression. These results provide evidence that con-
tradicts the presence of behavioral sex disparities and thus 
support a biologic underlying factor. (J Clin Oncol 31:2337–
46, 2013) Selected by T. Nijsten
Split second
In the initiation of adaptive immune responses, T-lymphocyte 
detection of foreign material presented by professional anti-
gen-presenting cells (APCs) is a key step. To understand the 
antigen detection process at the molecular level, Brodovitch 
and colleagues employed total internal reflection fluores-
cence microscopy to determine the precise frequency and 
duration of T-cell/APC membrane contacts and examine how 
membrane motions are altered upon T cell–receptor (TCR) 
detection of a cognate peptide–major histocompatibility 
complex molecule. T cells generated transient second-scale 
contacts with submicrometer-diameter microvilli. TCR ligand 
detection generated a pulling motion within 10 s, and accu-
mulation of 30–40 of these recognition events in one min-
ute generated active spreading. Thus, these studies revealed 
that T lymphocytes sense antigens within seconds and make 
a decision within one minute, providing insight into the 
mechanism of antigen detection and signaling by T cells. (J 
Immunol 191:2064–71, 2013) Selected by S. Hwang
Looking beneath the surface of EGFR 
inhibition
Altered signaling through the EGFR has been implicated in 
the development of various cancers; thus, cancer patients 
have been treated somewhat effectively with EGFR inhibi-
tors (EGFRIs). Unfortunately, cancer patients treated with 
these inhibitors frequently experience cutaneous toxicities, 
including acneiform rash, dry and itchy skin, and microbial 
infections, often resulting in discontinuation of treatment. 
Interestingly, the presence and severity of these cutaneous 
symptoms are directly correlated with a positive tumor 
response, suggesting a common mode of action against 
tumors and in skin. Two recently published companion 
papers demonstrated the effects of cutaneous EGFR defi-
ciency in mice and in human cancer samples. The first paper, 
by Mascia and colleagues, explored this issue in mice with 
epidermal targeted ablation of EGFR. These mice exhibited 
local inflammation, pruritus, altered keratinocyte differen-
tiation, alopecia, and systemic inflammation, reminiscent 
of cancer patients treated with EGFRI. This model revealed 
that macrophages and mast cells respond early, followed by 
eosinophils, T cells, and neutrophils. These mice exhibited 
an early induction of the inflammatory response followed 
by altered epithelial differentiation. Macrophage depletion 
improved the skin phenotype in the conditional EGFR 
knockout mice.
In the second paper, Lichtenberger and colleagues 
also employed epidermis-specific EGFR knockout mice 
and demonstrated that epidermal keratinocytes control 
cutaneous immunity via effects on innate immune cell–driven 
inflammation, barrier function, and antimicrobial defense. In 
the conditional knockout mice, impaired EGFR resulted in an 
uncontrolled chemokine-driven inflammatory cascade, which 
was worsened by impaired skin barrier and antimicrobial 
defense. A strong infiltrate of mast cells and neutrophils 
in epidermal EGFR knockout mice was concomitant with 
a switch from γδ T cells to αβ T cells. These findings reflect 
changes observed in cells from cancer patients receiving 
EGFRI treatment. Together, these studies shed light on the 
mechanisms of EGFRI antitumor effects and related skin 
toxicity and offer avenues for modulation of the pathway to 
minimize the unwanted side effects of therapy. (Sci Transl 
Med 5:199ra110, 2013; Sci Transl Med 5:199ra111, 2013) 
Selected by B. Gilchrest and S. Yuspa, respectively
The itch circuit
Itch is triggered through somatosensory neurons, and previous 
studies have highlighted the importance of itch signaling path-
ways that involve the ion channel transient receptor potential 
cation channel subfamily V member 1 (TRPV1). To date, the 
mechanisms of this nociceptive response are not well under-
stood. Using a microarray screen to identify TRPV1-enriched 
transcripts, Mishra and Hoon recently identified natriuretic 
polypeptide b (Nppb) as a candidate molecule that mediates 
itch signaling. These studies showed that Nppb expression 
marks a subset of somatosensory neurons that detect pruritic 
agents. Indeed, mice lacking Nppb were insensitive to the pru-
ritic agents. In addition, Nppb secretion from these neurons 
is necessary and sufficient for an itch response to all of these 
agents. These findings may lead to the development of novel 
therapies to overcome the challenging problem of chronic 
itch. (Science 340:968, 2013) Selected by T. DarlingJournal of Investigative Dermatology (2013) 133, 2658. doi:10.1038/jid.2013.408
